DebasishBanerjee United KingdomSt George's University Hospital NHS Foundation Tr

DebasishBanerjee
Debasish Banerjee is the Clinical Lead of the Department of Renal Medicine and Transplantation and Co-Director of the Translational and Clinical Research Institute at St George's University Hospitals NHS Foundation Trust, with special interest in cardiovascular complications of chronic kidney disease. He established the multidisciplinary CKD-heart failure clinic and Cardio-Kidney-Metabolic clinic in St George’s Hospital. He is a Professor of Renal Medicine and Quality Lead for the MBBS Program at City St George's, University of London.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Innovations in Transplantation
CHAL01
Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD
MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deGermanyUniversity hospital Erlangen
  • Update in Robotic Kidney Transplantation
    RajeshSivaprakasam Speaker United Kingdom
  • Progress in Xenotransplantation
    MeganSykes Speaker ms3976@cumc.columbia.eduUnited States
  • Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation
    CarolineLamarche Speaker caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal
  • Post Transplant TMA-pathogenesis and Management
    LilianMonteiro P. Palma Speaker lilian.palma@icloud.comBrazilState University of Campinas
  • Q and A
Hall A
10:30 a.m.
11 a.m.
Hitting the Four Hits: The Potential of Dual BAFF/APRIL Inhibition in IgA Nephropathy
SPOT-O3
JonathanBarratt Spotlight Speaker United KingdomUniversity of Leicester, Leicester, UK
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)
PL2
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja
Hall A
12:15 p.m.
1:15 p.m.
Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session
CHAL1001
Domingo Casadei Chairperson drdomingocasadei@gmail.com
VivekanandJha Chairperson IndiaGeorge Institute for Global Health India
  • How to Achieve Transparent and Regulated Organ Donation and Transplantation
    Maria AmaliaMatamoros Speaker Costa RicaCaja Costarricense del Seguro social
  • Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism
    LilianaBisigniano Speaker lbisigniano@incucai.gov.arArgentinaLiliana Bisigniano MD
  • How to Handle Cases of Presumed Transplant Tourism
    KenSakai Speaker kensakai@med.toho-u.ac.jpJapanDepartment of Nephrology, Toho University Omori Medical Center
  • Q and A
Hall C1
2:45 p.m.
3:30 p.m.
What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C)
SPOT-06
ErangaWijewickrama Spotlight Chairperson Sri LankaFaculty of Medicine, University of Colombo
Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)
Magdalena Madero Spotlight Speaker MexicoChief of Nephrology, Instituto Nacional de Cardiol
VivekanandJha Spotlight Speaker IndiaGeorge Institute for Global Health India
NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka
Spotlight Stage 1 (exhibition hall)
3 p.m.
4 p.m.
Cardiorenal Syndrome: Updates in the Pathophysiology and State-of-the-Art Treatment
IK01
FelipeInserra Chairperson felipe.inserra@gmail.comArgentina
YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • New Insights into the Mechanisms of Kidney Injury in the CRS
    WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States
  • Novel Pharmacological Treatments of the CRS
    MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center
  • Device-related Treatment for CRS
    ClaudioRonco Speaker cronco@goldnet.itItalyInternational Renal Research Institute of Vicenza
  • Q and A
Hall D
4 p.m.
4:30 p.m.
Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis
SPOT-07
BradRovin Spotlight Speaker United StatesThe Ohio State University
UptalPatel Spotlight Speaker United States
Spotlight Stage 1 (exhibition hall)
4:30 p.m.
5:30 p.m.
New Developments in CKD Epidemiology Research
IK1001
MaartenTaal Chairperson United KingdomUniversity of Nottingham
RobertoPecoits Filho Chairperson United StatesArbor Research Collaborative for Health
  • Big Data Lab
    LAB-01
  • Patient-reported Outcome Measures: How Do Patients Experience CKD?
    AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care
  • Trial Simulation Using Observational Data
    AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health
  • Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges
    DorotheaNitsch Speaker United KingdomLondon School of Hygiene & Tropical Medicine
  • Q and A
Hall C4

Day 2 - Monday April 15, 2024

Time Session
12:15 p.m.
1:15 p.m.
The Journey of a Patient with Kidney and Cardiovascular Diseases: From Detection to Referral to Co-management
IK1002
RobertoPecoits Filho Chairperson United StatesArbor Research Collaborative for Health
  • Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease
    MarisolTorres Toledano Speaker torres.t.marisol@gmail.comMexicoIMSS, MEXICO
  • Co-management of Patients With Cardio-Kidney Diseases: Let
    DebasishBanerjee Speaker United KingdomSt George's University Hospital NHS Foundation Tr
  • Co-management of Patients With Cardio-Kidney Diseases: Let
    CharlesHerzog Speaker Charles.Herzog@cdrg.orgUnited StatesISN and Hennepin Healthcare/University of Minnes
  • Q and A
Hall C1

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10 a.m.
Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment
LF1002
DebasishBanerjee Chairperson United KingdomSt George's University Hospital NHS Foundation Tr
MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Setting the Scene
    MegJardine Speaker AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • DM and CKD: Which Treatment Should I Use for Different Populations?
    KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
  • How to Design Studies on Answering Unanswered Questions
    VladoPerkovic Speaker AustraliaUniversity of New South Wales, Sydney, Australia
  • The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes
    DavidWheeler Speaker United KingdomUniversity College London
  • Q and A
Hall C4